Khat – a controversial plant

  • Erica E. Balint
  • George Falkay
  • Gabor A. BalintEmail author
Review article


Khat (Catha edulis) is a shrub or tree whose leaves have been chewed for centuries by people who live in the Eastern part of Africa and the Arabian Peninsula. It has recently turned up in North America and Europe, particularly among emigrants and refugees from countries such as Somalia, Ethiopia and Yemen. Khat contains a number of chemicals, among which are two controlled substances, cathinone (Schedule I) and cathine (Schedule IV). Both chemicals are stimulant drugs with effects similar to amphetamine. Chewing the leaves makes people feel more alert and talkative, and suppresses appetite. Chewing khat leaves releases cathinone, a stimulant that produces the feeling of euphoria. When cathinone is broken down in the body, it produces chemicals including cathine and norephedrine, which have a similar structure to amphetamine and adrenaline (epinephrine). Regular khat use is associated with a rise in arterial blood pressure and pulse rate, corresponding with levels of cathinone in the plasma. Moreover, regular khat chewers have gingivitis and loose teeth, but there appears to be no convincing unusual incidence of oral cancer. Among khat users in Yemen there is, however, a higher incidence of esophageal cancer compared with gastric cancer. Long term use or abuse can cause insomnia, anorexia, gastric disorders, depression, liver damage and cardiac complications, including myocardial infarction. Manic and delusional behavior, violence, suicidal depression, hallucinations, paranoia and khat-induced psychosis have also been reported. On the basis of the scientific data it seems clear that khat use has negative consequences on the economic development of a country and on the health of the society.


Catha edulis Khat Chemistry Pharmacology Adverse effects Control Socioeconomic considerations 


  1. Kiple K, Ornelas KC (2001) The Cambridge world history of food. Cambridge Univ Press, ISBN: 0-521-402-166Google Scholar
  2. Balint GA, Ghebrekidan H, Balint EE (1991) Catha edulis, an international socio-medical problem with considerable pharmacological implications. E Afr Med J 68: 555–561Google Scholar
  3. Al-Hebshi NN, Skaug N (2005) Khat (Catha edulis) – an updated review. Addic Biol 10: 299–307CrossRefGoogle Scholar
  4. Krizevski R, Dudai N, Bar E, et al (2007) Developmental patterns of phenyl-propylamino alkaloids accumulation in khat (Catha edulis Forsk). J Ethnopharmacol 114: 432–438PubMedCrossRefGoogle Scholar
  5. Kassim S, Croucher R (2006) Khat chewing amongst UK resident male Yemeni adults: an explanatory study. Internat Dental J 56: 97–101Google Scholar
  6. VPOP – Hungarian Customs and Excise (2008) Ujfajta kabitoszert foglaltak le a vamosok (A new narcotic drug has been confiscated at Hungary's Ferihegy airport.) 31009/59-2008. (12 June) (Hungary) URL:
  7. United Nations Office for Drug Control and Crime Prevention (1999) The Drug Nexus in Africa. ODCCP Studies on Drug and Crime Monographs, ViennaGoogle Scholar
  8. Kirby A (2007) Yemen's khat habit soaks up water. URL:
  9. DEA (2006) Operation Somalia Express: largest khat enforcement ever. DEA News Release, 26 JulyGoogle Scholar
  10. Nencini P, Ahmed AM (1989) Khat consumption: a pharmacological review. Drug Alcohol Depend 23: 19–29PubMedCrossRefGoogle Scholar
  11. Kalix P, Braenden O (1985) Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 37: 149–164PubMedGoogle Scholar
  12. Szendrei K (1980) The chemistry of khat. Bull Narcotics 32: 5–36Google Scholar
  13. Kalix P (1984) The pharmacology of khat. General Pharmacol 15: 179–187Google Scholar
  14. Kalix P (1988) A plant with amphetamine effects. J Substances Abuse Treat 5: 163–169CrossRefGoogle Scholar
  15. Kalix P (1990) Pharmacological properties of the stimulant khat. Pharmacol Therap 48: 397–416CrossRefGoogle Scholar
  16. Kalix P (1992) Cathinone, a natural amphetamine. Pharmacol Toxicol 70: 77–86PubMedCrossRefGoogle Scholar
  17. Kalix P, Geisshusler S, Brenneisen R (1987) The effect of phenylpentenyl-khatamines on the release of radioactivity from rat striatal tissue prelabelled with/3H/-dopamine. J Pharm Pharmacol 39: 135–137PubMedGoogle Scholar
  18. Maitai CK (1977) The toxicity of the plant Catha edulis in rats. Toxicon 15: 363–366PubMedCrossRefGoogle Scholar
  19. WHO (1980) Review of the pharmacology of khat. Report of a WHO Advisory Group. Bull Narc 32: 83–93Google Scholar
  20. Brenneisen R, Geisshusler S (1985) Psychotropic drugs III. Analytical and chemical aspects of Catha edulis Forsk. Pharm Acta Helv 60: 290–301PubMedGoogle Scholar
  21. Geisshusler S, Brenneisen R (1987) The content of psychoactive phenyl-propyl and phenylpentenyl khatamines in Catha edulis Forsk of different origin. J Ethnopharmacol 19: 269–277PubMedCrossRefGoogle Scholar
  22. Toennes SW, Harder S, Schramm M, et al (2003) Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br J Clin Pharmacol 56: 125–130PubMedCrossRefGoogle Scholar
  23. Widler P, Mathys K, Brenneisen R, et al (1994) Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmacol Ther 55: 556–562PubMedGoogle Scholar
  24. Al Motarreb A, Baker K, Broadley KJ (2002) Khat: pharmacological and medical aspects and its social use in Yemen. Phytother Res 16: 403–413PubMedCrossRefGoogle Scholar
  25. Hassan NAGM, Gunaid AA, El-Khally FMY, et al (2002) The subjective effects of chewing Qat leaves in human volunteers. Ann Saudi Med 22: 34–37PubMedGoogle Scholar
  26. Islam MW, Al-Shabanah OA, Al-Harbi MM, et al (1994) Evaluation of teratogenic potential of khat (Catha edulis Forsk) in rats. Drug Chem Toxicol 17: 51–68PubMedCrossRefGoogle Scholar
  27. Banjaw MI, Miczek K, Schmidt WJ (2006) Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats. J Neural Transm 113: 543–556PubMedCrossRefGoogle Scholar
  28. Zelger JL, Schorno HX, Carlini EA (1980) Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine. Bull Narcotics 32: 67–81Google Scholar
  29. Goudie AJ (1985) Comparative effects of cathinone and amphetamine on fixed-interval operant responding: a rate-dependency analysis. Pharmacol Biochem Behav 23: 355–365PubMedCrossRefGoogle Scholar
  30. Peterson DW, Maitai CK, Sparber SB (1980) Relative potencies of two phenylalkylamines found in the abused plant Catha edulis, khat. Life Sci 27: 2143–2147PubMedCrossRefGoogle Scholar
  31. Schechter MD (1986) Dopaminergic mediation of a behavioral effect of l-cathinone. Pharmacol Biochem Behav 25: 337–340PubMedCrossRefGoogle Scholar
  32. Calcagnetti DJ, Schechter MD (1992) Psychostimulant-induced activity is attenuated by two putative dopamine release inhibitors. Pharmacol Biochem Behav 43: 1023–1031PubMedCrossRefGoogle Scholar
  33. Al-Motarreb AL, Broadley KJ (2003) Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton Autacoid Pharmacol 23: 319–326PubMedCrossRefGoogle Scholar
  34. Brenneisen R, Fisch HU, Koelbing U, et al (1990) Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol 30: 825–828PubMedGoogle Scholar
  35. Kohli JD, Goldberg LI (1982) Cardiovascular effects of (–)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J Pharm Pharmacol 34: 338–340PubMedGoogle Scholar
  36. Al-Motarreb A, Al-Kebsi M, Al-Adhi B, et al (2002) Khat chewing and acute myocardial infarction. Heart 87: 279–280PubMedCrossRefGoogle Scholar
  37. Ahmed MB, El-Qirbi AB (1993) Biochemical effects of Catha edulis, cathine and cathinone on adrenocortical functions. J Ethnopharmacol 39: 213–216PubMedCrossRefGoogle Scholar
  38. Islam MW, Tariq M, Ageel MM, et al (1990) An evaluation of the male reproductive toxicity of cathinone. Toxicology 60: 223–234PubMedCrossRefGoogle Scholar
  39. Al-Mamary M, Al-Habori M, Al-Aghbari AM, et al (2002) Investigation into the toxicological effects of Catha edulis leaves: a short term study in animals. Phytother Res 16: 127–132PubMedCrossRefGoogle Scholar
  40. Mwenda JM, Owuor RA, Kyama CM, et al (2006) Khat (Catha edulis) upregulates testosterone and decreases prolactin and cortisol levels in the baboon. J Ethnopharmacol 103: 379–384PubMedCrossRefGoogle Scholar
  41. Jansson T, Kristiansson B, Qirbi A (1988) Effect of khat on uteroplacental blood flow in awake, chronically catheterized, late-pregnant guinea pigs. J Ethnopharmacol 23: 19–26PubMedCrossRefGoogle Scholar
  42. Jansson T, Kristiansson B, Qirbi A (1988) Effect of khat on maternal food intake, maternal weight gain and fetal growth in the late-pregnant guinea pig. J Ethnopharmacol 23: 11–17PubMedCrossRefGoogle Scholar
  43. Nasher AA, Qirbi AA, Ghafoor MA, et al (1995) Khat chewing and bladder neck dysfunction. A randomized controlled trial of alpha-1-adrenergic blockade. Br J Urol 75: 597–598PubMedCrossRefGoogle Scholar
  44. Kalix P, Brenneisen R, Koelbing U, et al (1991) Khat, a herbal drug with amphetamine properties. Schweiz Med Wochenschr 121: 1561–1566PubMedGoogle Scholar
  45. Hassan NA, Gunaid AA, El-Khally FM, et al (2005) Khat chewing and arterial blood pressure. A randomized controlled trial of alpha-1 and selective beta-1 adrenoreceptor blockade. Saudi Med J 26: 537–541PubMedGoogle Scholar
  46. Nencini P, Ahmed AM, Elmi AS (1986) Subjective effects of khat chewing in humans. Drug Alcohol Depend 18: 97–105PubMedCrossRefGoogle Scholar
  47. Hassan NA, Gunaid AA, Abdo-Rabbo AA, et al (2000) The effect of Qat chewing on blood pressure and heart rate in healthy volunteers. Trop Doct 30: 107–108PubMedGoogle Scholar
  48. Tesfaye F, Byass P, Wall S, et al (2008) Association of smoking and khat (Catha edulis Forsk) use with high blood pressure among adults in Addis Ababa, Ethiopia, 2006. Prev Chronic Dis 5 (3): A89PubMedGoogle Scholar
  49. Nencini P, Ahmed AM, Amiconi G, et al (1984) Tolerance develops to sympathetic effects of khat in humans. Pharmacology 28: 150–154PubMedCrossRefGoogle Scholar
  50. Gunaid AA, El-Khally FM, Hassan NA, et al (1999) Chewing khat leaves slows the whole gut transit time. Saudi Med J 20: 444–447Google Scholar
  51. Halket JM, Karasu Y, Murray-Lyon IM (1995) Plasma cathinone levels (Catha edulis Forsk). J Ethnopharmacol 49: 111–113PubMedGoogle Scholar
  52. Brenneisen, Geisshusler S, Schorno X (1986) Metabolism of cathinone to (–)-norephedrine and (–)-norpseudoephedrine. J Pharm Pharmacol 38: 298–300PubMedGoogle Scholar
  53. Maitai CK, Mugera GM (1975) Excretion of the active principle of Catha edulis (Miraa) in human urine. J Pharm Sci 64: 702–703PubMedCrossRefGoogle Scholar
  54. Cox G, Rampes H (2003) Adverse effects of khat: a review. Adv Psychiatr Treat 9: 456–463CrossRefGoogle Scholar
  55. Halbach H (1972) Medical aspects of the chewing of khat leaves. Bull World Health Org 47: 21–29PubMedGoogle Scholar
  56. Tariq M, Al-Meshal I, Al-Saleh A (1983) Toxicity studies on Catha edulis. Dev Toxicol Environ Sci 11: 337–340PubMedGoogle Scholar
  57. Dhaifalah I, Santavy J (2004) Khat habit and its health effect. A natural amphetamine. Bioned Pap Med Fac Univ Palacky Olomouc Czech Rep 148: 11–15Google Scholar
  58. Pennings EJ, Opperhuizen A, van Amsterdam JG (2008) Risk assessment of khat use in the Netherlands. A review based on adverse health effects, prevalence, criminal involvement and public order. Regul Toxicol Pharmacol 52: 199–207PubMedCrossRefGoogle Scholar
  59. Al-Kadi HO, Noman MA, Al-Thobhani AK, et al (2002) Clinical and experimental evaluation of the effect of Khat-induced myocardial infarction. Saudi Med J 23: 1195–1198Google Scholar
  60. Mujlli HM, Bo X, Yhang L (2005) The effect of Khat (Catha edulis) on acute cerebral infarction. Neurosciences 10: 219–222Google Scholar
  61. Al-Hadrani AM (2000) Khat induced hemorrhoidal disease in Yemen. Saudi Med J 21: 475–477PubMedGoogle Scholar
  62. Kalix P (1980) Hyperthermic response to (–)-cathinone, an alkaloid of Catha edulis (khat). J Pharm Pharmacol 32: 662–663PubMedGoogle Scholar
  63. Balint GA, Desta B, Balint EE, et al (1990) Investigation of the traditionally used Ethiopian medicinal plants with modern up-to-date pharmacological methods. (Catha edulis, khat.) A joint WHO/UNDP/World Bank project. Addis Ababa University; School of Pharmacy, Department of Pharmacology. Report to the WHOGoogle Scholar
  64. Hill CM, Gibson A (1987) The oral and dental effects of q'at chewing. Oral Surg Oral Med Oral Pathol 63: 433–436PubMedCrossRefGoogle Scholar
  65. Kennedy JG, Teague J, Rokaw W, et al (1983) A medical evaluation of the use of qat in North Yemen. Soc Sci Med 17: 783–793PubMedCrossRefGoogle Scholar
  66. Jorgensen E, Kaimenyi JT (1990) The status of periodontal health and oral hygiene of Miraa (Catha edulis) chewers. East Afr Med J 67: 585–590PubMedGoogle Scholar
  67. Macigo FG, Mwaniki DL, Guthua SW (1995) The association between oral leukoplakia and use of tobacco, alcohol and khat based on relative risk assessment in Kenya. Eur J Oral Sci 103: 268–273PubMedCrossRefGoogle Scholar
  68. Pantelis C, Hindler CG, Taylor JC (1989) Use and abuse of khat (Catha edulis): a review of distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol Med 19: 657–668PubMedCrossRefGoogle Scholar
  69. Raja'a YA, Noman TA, Al-Mashrabi NA, et al (2000) Khat chewing is a risk factor of duodenal ulcer. Saudi Med J 21: 887–888PubMedGoogle Scholar
  70. Raja'a YA, Noman TA, Al-Warafi AK (2001) Khat chewing is a risk factor of duodenal ulcer. East Med Health J 7: 568–570Google Scholar
  71. Kekes Szabo A (1974) Kiserletes gyomorfekelyek farmakologiai befolyasolasa. (Pharmacological influence of experimental gastric ulcers.) Inaug. C.Sc. Thesis, Hung Acad Sci Budapest (Hungary)Google Scholar
  72. Balint GA (1987) Az endogen es az exogen prostacyclin szerepe a gyomorbel rendszer nyalkahartyajaban, elettanies koros korulmenyek kozott. (The role of the endogenous and exogenous prostacyclin in the gastrointestinal mucosa under physiological and pathological circumstances.) Inaug D.Sc. Thesis, Hung Acad Sci, Budapest (Hungary)Google Scholar
  73. Balint GA (1998) A possible molecular basis for the effect of gastric ant-ulcerogenic drugs. Trends in Pharmacol Sci (TiPS) 19: 401–403CrossRefGoogle Scholar
  74. Balint GA (2002) On a possible interrelationship among smoking, gastric ulceration and endogenous prostacyclin. Exp Toxic Pathol 54: 39–41CrossRefGoogle Scholar
  75. Balint GA, Nafradi J (2003) The possible role of mucosal endogenous prostacyclin in human peptic ulcer disease. J Appl Res 3: 41–45Google Scholar
  76. Mwenda JM, Arimi MM, Kyama MC et al (2003) Effects of khatt (Catha edulis) consumption on reproductive functions: a review. East Afr Med J 80: 318–323PubMedGoogle Scholar
  77. Goldenverg D, Lee J, Koch WM, et al (2004) Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg 131: 986–993CrossRefGoogle Scholar
  78. Makki I (1975) Oral carcinomas and their relationship to khat and shamma abuses. Thesis, University of Heidelberg (Germany)Google Scholar
  79. Soufi HE, Kameswaran M, Malatani T (1991) Khat and oral cancer. J Laryngol Otol 1205: 643–645Google Scholar
  80. Dhadphale M, Mengech A, Chege SW (1981) Miraa (Catha edulis) as a cause of psychosis. East Afr Med J 58: 130–135PubMedGoogle Scholar
  81. Critchlow S, Seifert R (1987) Khat-induced paranoid psychosis. Br J Psychiatry 150: 247–249PubMedCrossRefGoogle Scholar
  82. Dhadphale M, Omolo OE (1988) Psychiatric morbidity among khat chewers. East Afr Med J 65: 355–359PubMedGoogle Scholar
  83. Jager AD, Sireling L (1994) Natural history of khat psychosis. Aust NZ J Psychiatr 28: 331–332CrossRefGoogle Scholar
  84. Pantelis C, Hindler CG, Taylor JC (1989) Khat, toxic reactions to this substance, its similarities to amphetamine, and the implications of treatment for such patients. J Subst Abuse Treat 6: 205–206PubMedCrossRefGoogle Scholar
  85. Nielen RJ, van der Heijden FM, Tuinier S, et al (2004) Khat and mushrooms associated with psychosis. World J Biolo Psychiatr 5: 49–53CrossRefGoogle Scholar
  86. Granek M, Shalev A, Weingarten AM (1988) Khat-induced hypnagogic hallucinations. Acta Psychiatr Scand 78: 458–461PubMedCrossRefGoogle Scholar
  87. Kassie F, Darroudi F, Kundi M, et al (2001) Khat (Catha edulis) consumption causes genotoxic effects in humans. Int J Cancer 92: 329–332PubMedCrossRefGoogle Scholar
  88. Elmi A (1983) The chewing of khat in Somalia. J Ethnopharmacol 8: 163–176PubMedCrossRefGoogle Scholar
  89. Zein AZ, Mekkonen A, Moges T, et al (1984) Patterns of cigarette smoking among Ethiopian medical and paramedical university students in northwestern Ethiopia. Ethiop Med J 65: 309–318Google Scholar
  90. Belew M, Kebede D, Kassaye M, et al (2000) The magnitude of khat use and its association with health, nutrition and socio-economic status. Ethiop Med J 38: 11–26PubMedGoogle Scholar
  91. Kebede D, Alem A, Mitike G, et al (2005) Khat and alcohol use and risky sex behaviour among in-school and out-of-school youth in Ethiopia. BMC Publ Health 5: 109CrossRefGoogle Scholar
  92. Beckerleg S (2006) What harm? Kenyan and Ugandan perspectives of khat. African Affaires 105: 219–241CrossRefGoogle Scholar
  93. Beckerleg S (2008) Khat in East Africa: taking women into or out of sex work? Subst Use Misuse 43: 1170–1185PubMedCrossRefGoogle Scholar
  94. Carrier N (2008) Is miraa a drug? Categorizing Kenyan khat. Subst Use Misuse 43: 803–818PubMedCrossRefGoogle Scholar
  95. Aden A, Dimba EA, Ndolo UM, et al (2006) Socio-economic effects of khat chewing in eastern Kenya. East Afr Med J 83: 69–73PubMedGoogle Scholar
  96. Hasan NA, Gunaid AA, Murray-Lyon IM (2007) Khat (Catha edulis): health aspects of khat chewing. East Mediterr Health J 13: 706–718Google Scholar
  97. Odenwald M, Lingenfelder B, Schauer M, et al (2007) Screening for post-traumatic stress disorder among Somali ex-combatants: a validation study. Confl Health 1: 10PubMedCrossRefGoogle Scholar
  98. Odenwald M, Neuner F, Schauer M, et al (2005) Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia. BMC Med 3: 5PubMedCrossRefGoogle Scholar
  99. Kalix P (1991) The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol 32: 201–208PubMedCrossRefGoogle Scholar
  100. Kalix P (1994) Khat, an amphetamine-like stimulant. J Psychoactive Drugs 26: 69–74PubMedGoogle Scholar
  101. Patel NB (2000) Mechanism of action of cathinone, the active ingredient of Khat (Catha edulis). East Afr Med J 77: 329–332PubMedGoogle Scholar
  102. Giannini AJ, Miller NS, Turner CE (1992) Treatment of khat addiction. J Subst Abuse Treat 9: 379–382PubMedCrossRefGoogle Scholar
  103. Luqman W, Danowski TS (1976) The use of khat (Catha edulis) in Yemen, Social and medical observations. Ann Intern Med 85: 246–249PubMedGoogle Scholar
  104. Feyissa AM, Kelly JP ( 2008) A review of the neuropharmacological properties of khat. Prog Neuropsychopharmacol Biol Psychiatry 32: 1147–1166PubMedCrossRefGoogle Scholar
  105. Numan N (2004) Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 99: 61–65PubMedCrossRefGoogle Scholar
  106. Graziani M, Milella MS, Nencini P (2008) Khat chewing from the pharmacological point of view: an update. Subst Use Misuse 43: 762–783PubMedCrossRefGoogle Scholar
  107. Selassie SG, Gebre A (1996) Rapid assessment of drug abuse in Ethiopia. Bull Narc 48: 53–63PubMedGoogle Scholar
  108. Bimerew MS, Sonn FC, Kortenbout WP (2007) Substance abuse and the risk of readmission of people with schizophrenia at Amanuel Psychiatric Hospital, Ethiopia. Curations 30: 74–81Google Scholar
  109. BhuiK, Abdi A, Abdi M, et al (2003) Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees. Soc Psychiatry Psychiatr Epidemiol 38: 35–43CrossRefGoogle Scholar
  110. Griffiths P, Gossop M, Wickenden S, et al (1997) A trans-cultural pattern of drug use: qat (khat) in the UK. Br J Psychiatr 170: 281–284CrossRefGoogle Scholar
  111. WHO (2003) WHO Expert Committee on Drug Dependence. 33rd Report. WHO Tech Rep Ser No. 915Google Scholar
  112. WHO (2006) WHO Expert Committee on Drug Dependence. 34th Report. WHO Tech Rep Ser No. 942Google Scholar
  113. WHO (2006) WHO Expert Committee on Drug Dependence. Critical Review of Khat. Expert Committee Meeting, 28–31 March, GenevaGoogle Scholar
  114. Belhadi-Tahar H, Sadeq N (2005) Methcathinone: a new postindustrial drug. Forensic Sci Int 153: 99–101CrossRefGoogle Scholar
  115. WHO (1995) WHO Expert Committee on Drug Dependence. 29th Report. WHO Tech Rep Ser No. 856Google Scholar
  116. UN (1971) UN International Drug Control Conventions. Convention on Psychotropic Substances. URL:
  117. Graw B (2006) House of Commons. Drug classification: making a hash of it? URL:
  118. Bentur Y, Bloom-Krasik A, Raikhlin-Eisenkraft B (2008) Illicit cathinone ("Hagigat") poisoning. Clin Toxicol (Phila) 46: 206–210Google Scholar
  119. BBC (2009) Ethiopia clamps down on khat dens. (Jan. 2008) URL:
  120. Dizikes C (2009) Khat: Is it more coffee or cocaine? URL:

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Erica E. Balint
    • 1
  • George Falkay
    • 2
  • Gabor A. Balint
    • 3
    Email author
  1. 1.Department of Human Anatomy, Faculty of MedicineUniversity of SzegedSzegedHungary
  2. 2.Department of Pharmacodynamics, Faculty of PharmacyUniversity of SzegedSzegedHungary
  3. 3.Laboratory of Clinical Pharmacology, Department of Psychiatry, Faculty of MedicineAlbert Szent-Gyorgyi Clinical Center, New Clinics, University of SzegedSzegedHungary

Personalised recommendations